• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTCX:US

23.29 USD 0.21 0.91%

As of 09:29:30 ET on 01/23/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTCX)

Year To Date: +6.20% 3-Month: +15.91% 3-Year: +42.23% 52-Week Range: 15.42 - 23.32
1-Month: +9.96% 1-Year: +22.13% 5-Year: +31.58% Beta vs MXWO: 1.07

Mutual Fund Chart for FBTCX

No chart data available.
  • FBTCX:US 23.29
  • 1M
  • 1Y
Interactive FBTCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTCX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTCX

NAV (on 2015-01-23) 23.29
Assets (M) (on 2014-12-31) 2,227.90
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTCX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.59

Fees & Expenses for FBTCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.83

Top Fund Holdings for FBTCX

Filing Date: 11/30/2014
Name Position Value % of Total
Gilead Sciences Inc 2,341,830 234,932,386 11.261%
Celgene Corp 1,388,625 157,872,776 7.567%
Alexion Pharmaceuticals Inc 603,399 117,602,465 5.637%
Vertex Pharmaceuticals Inc 916,326 108,016,509 5.177%
Regeneron Pharmaceuticals Inc 245,500 102,155,005 4.896%
Receptos Inc 439,242 59,429,443 2.849%
Amgen Inc 320,517 52,984,665 2.540%
BioMarin Pharmaceutical Inc 559,632 50,210,183 2.407%
Medivation Inc 431,077 49,957,514 2.395%
Puma Biotechnology Inc 215,858 49,004,083 2.349%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil